1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Peptide Therapeutics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Injection 1.2.3 Oral 1.2.4 Other 1.3 Market by Application 1.3.1 Global Peptide Therapeutics Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Cancer 1.3.3 Metabolic Disorders 1.3.4 Central Nervous System 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Peptide Therapeutics Drugs Market Perspective (2016-2027) 2.2 Peptide Therapeutics Drugs Growth Trends by Regions 2.2.1 Peptide Therapeutics Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Peptide Therapeutics Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Peptide Therapeutics Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Peptide Therapeutics Drugs Industry Dynamic 2.3.1 Peptide Therapeutics Drugs Market Trends 2.3.2 Peptide Therapeutics Drugs Market Drivers 2.3.3 Peptide Therapeutics Drugs Market Challenges 2.3.4 Peptide Therapeutics Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Peptide Therapeutics Drugs Players by Revenue 3.1.1 Global Top Peptide Therapeutics Drugs Players by Revenue (2016-2021) 3.1.2 Global Peptide Therapeutics Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Peptide Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Peptide Therapeutics Drugs Revenue 3.4 Global Peptide Therapeutics Drugs Market Concentration Ratio 3.4.1 Global Peptide Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Peptide Therapeutics Drugs Revenue in 2020 3.5 Peptide Therapeutics Drugs Key Players Head office and Area Served 3.6 Key Players Peptide Therapeutics Drugs Product Solution and Service 3.7 Date of Enter into Peptide Therapeutics Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Peptide Therapeutics Drugs Breakdown Data by Type 4.1 Global Peptide Therapeutics Drugs Historic Market Size by Type (2016-2021) 4.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2022-2027) 5 Peptide Therapeutics Drugs Breakdown Data by Application 5.1 Global Peptide Therapeutics Drugs Historic Market Size by Application (2016-2021) 5.2 Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Peptide Therapeutics Drugs Market Size (2016-2027) 6.2 North America Peptide Therapeutics Drugs Market Size by Type 6.2.1 North America Peptide Therapeutics Drugs Market Size by Type (2016-2021) 6.2.2 North America Peptide Therapeutics Drugs Market Size by Type (2022-2027) 6.2.3 North America Peptide Therapeutics Drugs Market Size by Type (2016-2027) 6.3 North America Peptide Therapeutics Drugs Market Size by Application 6.3.1 North America Peptide Therapeutics Drugs Market Size by Application (2016-2021) 6.3.2 North America Peptide Therapeutics Drugs Market Size by Application (2022-2027) 6.3.3 North America Peptide Therapeutics Drugs Market Size by Application (2016-2027) 6.4 North America Peptide Therapeutics Drugs Market Size by Country 6.4.1 North America Peptide Therapeutics Drugs Market Size by Country (2016-2021) 6.4.2 North America Peptide Therapeutics Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Peptide Therapeutics Drugs Market Size (2016-2027) 7.2 Europe Peptide Therapeutics Drugs Market Size by Type 7.2.1 Europe Peptide Therapeutics Drugs Market Size by Type (2016-2021) 7.2.2 Europe Peptide Therapeutics Drugs Market Size by Type (2022-2027) 7.2.3 Europe Peptide Therapeutics Drugs Market Size by Type (2016-2027) 7.3 Europe Peptide Therapeutics Drugs Market Size by Application 7.3.1 Europe Peptide Therapeutics Drugs Market Size by Application (2016-2021) 7.3.2 Europe Peptide Therapeutics Drugs Market Size by Application (2022-2027) 7.3.3 Europe Peptide Therapeutics Drugs Market Size by Application (2016-2027) 7.4 Europe Peptide Therapeutics Drugs Market Size by Country 7.4.1 Europe Peptide Therapeutics Drugs Market Size by Country (2016-2021) 7.4.2 Europe Peptide Therapeutics Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Peptide Therapeutics Drugs Market Size (2016-2027) 8.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type 8.2.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application 8.3.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region 8.4.1 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Peptide Therapeutics Drugs Market Size (2016-2027) 9.2 Latin America Peptide Therapeutics Drugs Market Size by Type 9.2.1 Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Peptide Therapeutics Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2027) 9.3 Latin America Peptide Therapeutics Drugs Market Size by Application 9.3.1 Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Peptide Therapeutics Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2027) 9.4 Latin America Peptide Therapeutics Drugs Market Size by Country 9.4.1 Latin America Peptide Therapeutics Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Peptide Therapeutics Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Peptide Therapeutics Drugs Market Size (2016-2027) 10.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type 10.2.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application 10.3.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country 10.4.1 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Sanofi 11.1.1 Sanofi Company Details 11.1.2 Sanofi Business Overview 11.1.3 Sanofi Peptide Therapeutics Drugs Introduction 11.1.4 Sanofi Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.1.5 Sanofi Recent Development 11.2 Eli Lilly 11.2.1 Eli Lilly Company Details 11.2.2 Eli Lilly Business Overview 11.2.3 Eli Lilly Peptide Therapeutics Drugs Introduction 11.2.4 Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.2.5 Eli Lilly Recent Development 11.3 Novo Nordisk 11.3.1 Novo Nordisk Company Details 11.3.2 Novo Nordisk Business Overview 11.3.3 Novo Nordisk Peptide Therapeutics Drugs Introduction 11.3.4 Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.3.5 Novo Nordisk Recent Development 11.4 Takeda 11.4.1 Takeda Company Details 11.4.2 Takeda Business Overview 11.4.3 Takeda Peptide Therapeutics Drugs Introduction 11.4.4 Takeda Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.4.5 Takeda Recent Development 11.5 Teva 11.5.1 Teva Company Details 11.5.2 Teva Business Overview 11.5.3 Teva Peptide Therapeutics Drugs Introduction 11.5.4 Teva Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.5.5 Teva Recent Development 11.6 Novartis 11.6.1 Novartis Company Details 11.6.2 Novartis Business Overview 11.6.3 Novartis Peptide Therapeutics Drugs Introduction 11.6.4 Novartis Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.6.5 Novartis Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Company Details 11.7.2 AstraZeneca Business Overview 11.7.3 AstraZeneca Peptide Therapeutics Drugs Introduction 11.7.4 AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.7.5 AstraZeneca Recent Development 11.8 Ipsen 11.8.1 Ipsen Company Details 11.8.2 Ipsen Business Overview 11.8.3 Ipsen Peptide Therapeutics Drugs Introduction 11.8.4 Ipsen Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.8.5 Ipsen Recent Development 11.9 AbbVie 11.9.1 AbbVie Company Details 11.9.2 AbbVie Business Overview 11.9.3 AbbVie Peptide Therapeutics Drugs Introduction 11.9.4 AbbVie Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.9.5 AbbVie Recent Development 11.10 Allergan 11.10.1 Allergan Company Details 11.10.2 Allergan Business Overview 11.10.3 Allergan Peptide Therapeutics Drugs Introduction 11.10.4 Allergan Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.10.5 Allergan Recent Development 11.11 Ferring 11.11.1 Ferring Company Details 11.11.2 Ferring Business Overview 11.11.3 Ferring Peptide Therapeutics Drugs Introduction 11.11.4 Ferring Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.11.5 Ferring Recent Development 11.12 Merck 11.12.1 Merck Company Details 11.12.2 Merck Business Overview 11.12.3 Merck Peptide Therapeutics Drugs Introduction 11.12.4 Merck Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.12.5 Merck Recent Development 11.13 JNJ 11.13.1 JNJ Company Details 11.13.2 JNJ Business Overview 11.13.3 JNJ Peptide Therapeutics Drugs Introduction 11.13.4 JNJ Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.13.5 JNJ Recent Development 11.14 Tarix Pharmaceuticals 11.14.1 Tarix Pharmaceuticals Company Details 11.14.2 Tarix Pharmaceuticals Business Overview 11.14.3 Tarix Pharmaceuticals Peptide Therapeutics Drugs Introduction 11.14.4 Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.14.5 Tarix Pharmaceuticals Recent Development 11.15 Lonza 11.15.1 Lonza Company Details 11.15.2 Lonza Business Overview 11.15.3 Lonza Peptide Therapeutics Drugs Introduction 11.15.4 Lonza Revenue in Peptide Therapeutics Drugs Business (2016-2021) 11.15.5 Lonza Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Peptide Therapeutics Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Injection Table 3. Key Players of Oral Table 4. Key Players of Other Table 5. Global Peptide Therapeutics Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Peptide Therapeutics Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Peptide Therapeutics Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Peptide Therapeutics Drugs Market Share by Regions (2016-2021) Table 9. Global Peptide Therapeutics Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Peptide Therapeutics Drugs Market Share by Regions (2022-2027) Table 11. Peptide Therapeutics Drugs Market Trends Table 12. Peptide Therapeutics Drugs Market Drivers Table 13. Peptide Therapeutics Drugs Market Challenges Table 14. Peptide Therapeutics Drugs Market Restraints Table 15. Global Peptide Therapeutics Drugs Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Peptide Therapeutics Drugs Market Share by Players (2016-2021) Table 17. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics Drugs as of 2020) Table 18. Ranking of Global Top Peptide Therapeutics Drugs Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Peptide Therapeutics Drugs Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Peptide Therapeutics Drugs Product Solution and Service Table 22. Date of Enter into Peptide Therapeutics Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million) Table 25. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2016-2021) Table 26. Global Peptide Therapeutics Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Peptide Therapeutics Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2016-2021) Table 30. Global Peptide Therapeutics Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Peptide Therapeutics Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million) Table 33. North America Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million) Table 35. North America Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Peptide Therapeutics Drugs Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Peptide Therapeutics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Peptide Therapeutics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Peptide Therapeutics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 62. Sanofi Company Details Table 63. Sanofi Business Overview Table 64. Sanofi Peptide Therapeutics Drugs Product Table 65. Sanofi Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 66. Sanofi Recent Development Table 67. Eli Lilly Company Details Table 68. Eli Lilly Business Overview Table 69. Eli Lilly Peptide Therapeutics Drugs Product Table 70. Eli Lilly Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 71. Eli Lilly Recent Development Table 72. Novo Nordisk Company Details Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Peptide Therapeutics Drugs Product Table 75. Novo Nordisk Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 76. Novo Nordisk Recent Development Table 77. Takeda Company Details Table 78. Takeda Business Overview Table 79. Takeda Peptide Therapeutics Drugs Product Table 80. Takeda Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 81. Takeda Recent Development Table 82. Teva Company Details Table 83. Teva Business Overview Table 84. Teva Peptide Therapeutics Drugs Product Table 85. Teva Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 86. Teva Recent Development Table 87. Novartis Company Details Table 88. Novartis Business Overview Table 89. Novartis Peptide Therapeutics Drugs Product Table 90. Novartis Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 91. Novartis Recent Development Table 92. AstraZeneca Company Details Table 93. AstraZeneca Business Overview Table 94. AstraZeneca Peptide Therapeutics Drugs Product Table 95. AstraZeneca Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 96. AstraZeneca Recent Development Table 97. Ipsen Company Details Table 98. Ipsen Business Overview Table 99. Ipsen Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 100. Ipsen Recent Development Table 101. AbbVie Company Details Table 102. AbbVie Business Overview Table 103. AbbVie Peptide Therapeutics Drugs Product Table 104. AbbVie Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 105. AbbVie Recent Development Table 106. Allergan Company Details Table 107. Allergan Business Overview Table 108. Allergan Peptide Therapeutics Drugs Product Table 109. Allergan Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 110. Allergan Recent Development Table 111. Ferring Company Details Table 112. Ferring Business Overview Table 113. Ferring Peptide Therapeutics Drugs Product Table 114. Ferring Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 115. Ferring Recent Development Table 116. Merck Company Details Table 117. Merck Business Overview Table 118. Merck Peptide Therapeutics Drugs Product Table 119. Merck Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 120. Merck Recent Development Table 121. JNJ Company Details Table 122. JNJ Business Overview Table 123. JNJ Peptide Therapeutics Drugs Product Table 124. JNJ Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 125. JNJ Recent Development Table 126. Tarix Pharmaceuticals Company Details Table 127. Tarix Pharmaceuticals Business Overview Table 128. Tarix Pharmaceuticals Peptide Therapeutics Drugs Product Table 129. Tarix Pharmaceuticals Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 130. Tarix Pharmaceuticals Recent Development Table 131. Lonza Company Details Table 132. Lonza Business Overview Table 133. Lonza Peptide Therapeutics Drugs Product Table 134. Lonza Revenue in Peptide Therapeutics Drugs Business (2016-2021) & (US$ Million) Table 135. Lonza Recent Development Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global Peptide Therapeutics Drugs Market Share by Type: 2020 VS 2027 Figure 2. Injection Features Figure 3. Oral Features Figure 4. Other Features Figure 5. Global Peptide Therapeutics Drugs Market Share by Application: 2020 VS 2027 Figure 6. Cancer Case Studies Figure 7. Metabolic Disorders Case Studies Figure 8. Central Nervous System Case Studies Figure 9. Other Case Studies Figure 10. Peptide Therapeutics Drugs Report Years Considered Figure 11. Global Peptide Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Peptide Therapeutics Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Peptide Therapeutics Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Peptide Therapeutics Drugs Market Share by Regions (2022-2027) Figure 15. Global Peptide Therapeutics Drugs Market Share by Players in 2020 Figure 16. Global Top Peptide Therapeutics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Therapeutics Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Peptide Therapeutics Drugs Revenue in 2020 Figure 18. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Peptide Therapeutics Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Peptide Therapeutics Drugs Market Share by Type (2016-2027) Figure 22. North America Peptide Therapeutics Drugs Market Share by Application (2016-2027) Figure 23. North America Peptide Therapeutics Drugs Market Share by Country (2016-2027) Figure 24. United States Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Peptide Therapeutics Drugs Market Share by Type (2016-2027) Figure 28. Europe Peptide Therapeutics Drugs Market Share by Application (2016-2027) Figure 29. Europe Peptide Therapeutics Drugs Market Share by Country (2016-2027) Figure 30. Germany Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Peptide Therapeutics Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Peptide Therapeutics Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Peptide Therapeutics Drugs Market Share by Region (2016-2027) Figure 40. China Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Peptide Therapeutics Drugs Market Share by Type (2016-2027) Figure 48. Latin America Peptide Therapeutics Drugs Market Share by Application (2016-2027) Figure 49. Latin America Peptide Therapeutics Drugs Market Share by Country (2016-2027) Figure 50. Mexico Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Peptide Therapeutics Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Peptide Therapeutics Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Peptide Therapeutics Drugs Market Share by Country (2016-2027) Figure 56. Turkey Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Peptide Therapeutics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Sanofi Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 60. Eli Lilly Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 61. Novo Nordisk Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 62. Takeda Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 63. Teva Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 64. Novartis Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 65. AstraZeneca Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 66. Ipsen Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 67. AbbVie Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 68. Allergan Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 69. Ferring Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 70. Merck Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 71. JNJ Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 72. Tarix Pharmaceuticals Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 73. Lonza Revenue Growth Rate in Peptide Therapeutics Drugs Business (2016-2021) Figure 74. Bottom-up and Top-down Approaches for This Report Figure 75. Data Triangulation Figure 76. Key Executives Interviewed

Sanofi Eli Lilly Novo Nordisk Takeda Teva Novartis AstraZeneca Ipsen AbbVie Allergan Ferring Merck JNJ Tarix Pharmaceuticals Lonza